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Summary
The effect of an ethanolic extract of propolis, with and without CAPE, and some of its components
on cyclooxygenase (COX-1 and COX-2) activity in J774 macrophages has been investigated. COX-
1 and COX-2 activity, measaured as prostaglandin E2 (PGE2) production, were concentration-de-
pendently inhibited by propolis (3 · 10–3–3 · 102 µgml–1) with an IC50 of 2.7 µgml–1 and 4.8 · 10_2
µgml–1, respectively. Among the compounds tested pinocembrin and caffeic, ferulic, cinnamic and
chlorogenic acids did not affect the activity of COX isoforms. Conversely, CAPE (2.8 · 10–4–28
µgml–1; 10–9–10–4 M) and galangin (2.7 · 10–4–27 µgml–1; 10–9–10–4 M) were effective, the last being
about ten-twenty times less potent. In fact the IC50 of CAPE for COX-1 and COX-2 were 4.4 · 10–1
µgml–1 (1.5 · 10–6 M) and 2 · 10–3 µgml–1 (6.3 · 10–9 M), respectively. The IC50 of galangin were 3.7
µgml–1 (15 · 10–6 M) and 3 · 10–2 µgml–1 (120 · 10–9 M), for COX-1 and COX-2 respectively. To bet-
ter investigate the role of CAPE, we tested the action of the ethanolic extract of propolis deprived
of CAPE, which resulted about ten times less potent than the extract with CAPE in the inhibition
of both COX-1 and COX-2, with an IC50 of 30 µgml–1 and 5.3 · 10–1 µgml–1, respectively. Moreover
the comparison of the inhibition curves showed a significant difference (p < 0.001).These results
suggest that both CAPE and galangin contribute to the overall activity of propolis, CAPE being
more effective. 
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j Introduction
Propolis is a resinous material elaborated by honey bees
(Apis mellifera) well known for its medical effects, in-
cluding antinflammatory, antiviral, immunostimulatory
and carcinostatic activities (Dobrovolski et al., 1991).
The most used formulation in the folk medicine is the
ethanol extract (Mezenes et al., 1999). Standardization
of propolis preparations is indeed difficult because of
changes in chemical composition and pharmacological
activities, resulting from variation in geographical and
botanical origin (Ghisalberti, 1997). The wide spectrum
of propolis activities was mainly attributed to the large
number of flavonoids (Vennat et al., 1995). In addition to
flavonoids, propolis contains cinnamic derivatives such
as caffeic, ferulic, cinnamic, chlorogenic acids and its es-
ters (Mirzoeva and Calder, 1996). Recently it has been
reported that the caffeic acid phenethyl ester (CAPE), a
component of propolis, exherts a potent antinflammatory
activity. The antinflammatory properties of CAPE have
been attributed to the suppression of prostaglandin (PG)
and leukotrienes synthesis (Mirzoeva and Calder, 1996).
It has also been reported that CAPE inhibits in vitro and
in vivo histamine release in the rat (Scheller et al., 2000).
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PG, produced by cyclooxygenase (E. C. 1.14.991;
COX), are important antinflammatory mediators
(Vane, 1971). The enzyme is present in constitutive
(COX-1) and inducible (COX-2) isoform. The consti-
tutively expressed isoform release PG involved in
physiological events in various organs of the body. The
inducible isoform, which is expressed by several cell
types in response to inflammatory and immunological
stimuli, is responsible for the increased PG generation
at the inflammation site (Smith and Dewitt, 1995).
Unstimulated J774 macrophages possess a signifi-
cant COX-1 activity, whereas the immunostimulation
by endotoxin, such as lipopolysaccharides, results in a
significant induction of COX-2 and a down regulation
of COX-1 (Zingarelli et al., 1997).
The present study was designed to investigate the
role of CAPE and other components in the overall
antinflammatory activity of propolis. To this purpose
we have investigated the effect of an ethanolic extract
of propolis, with and without CAPE, and some of its
components on COX-1 and COX-2 activity, measured
as PGE2 production, in J774 macrophages.
j Materials and Methods
Drugs tested
• Propolis: The dried ethanol extract of propolis, with
and without CAPE, was obtained from Carlo Sessa,
Milan, Italy. 
Propolis extract is a commercial product consisting
of propolis deprived of waxes; it is usually obtained
from propolis by alcoolic extraction and normally
called “propolis”.
• Propolis deprived of CAPE: Ten g of propolis ex-
tract were dissolved in 150 ml of methanol and 30 ml
of 2N sulphuric acid were added. The vessel was tight-
ly capped and heated for 1 hour in a boiling water bath.
After cooling, the solution was neutralized to pH 7,0
with 25% ammonia solution and the methanol was ro-
tary evaporated under vacuum. The hydrolysis prod-
ucts (caffeic acid and phenethyl alcool) were removed
from the residual mass by extracting twice with 200 ml
water under reflux and discarding the water solutions.
The residue was finally dried under vacuum. The yield
was about 95%.
Original propolis, water solutions and residual
propolis were subjected to thin layer chromatography
(TLC) on silica gel using a fluorescent indicator
(Kieselgel 60 WF254). The developing solvent was:
toluene/ethyl formiate/formic acid 6/3/0.5. Reference
compounds were CAPE, caffeic acid and phenethyl al-
cool, revealed by UV lights (254 nm). Flavonoids and
other components were detected by a methanol solu-
tions of 1% 2-aminoethyl diphenylborate. CAPE and
caffeic acid were also revealed by this reagent (see
Fig. 1).
• Other compounds: CAPE, caffeic, ferulic, cinnamic,
chlorogenic acids and galangin were obtained from
Sigma-Aldrich, Milan, Italy. Pinocembrin was ob-
tained from Trimital, Milan, Italy. 
Stock solutions of test compounds were prepared in
ethanol, an equivalent amount of ethanol was included
in control samples. 
• Determination of total flavonoids (as galangine) and
caffeic acid contents in original and residual propolis:
Galangine was determined spectrophotometrically (Alì
et al., 1997), while caffeic acid was determined by
HPLC (Alì et al., 1997).
Materials
Arachidonic acid was obtained from SPIBIO, Paris,
France. [3H-PGE2] was from NEN Du Pont (Milan,
Italy). TLC plates were from Merck (Darmstadt, Ger-
many). Bacterial lipopolysaccharide from Salmonella
thyphosa (LPS) and all other reagents and com-
pounds used were obtained from Sigma-Aldrich,
Milan, Italy.
Cell culture
The murine monocyte/macrophage J774 cell line was
grown in Dulbecco’s modified Eagles medium
(DMEM) supplemented with 2mM glutamine, 25 mM
Hepes, penicillin (100 µ/ml), streptomycin (100
µgml–1), 10% foetal bovine serum (FBS) and 1.2% Na-
pyruvate (Bio Whittaker, Europe). Cells were plated in
24 well culture plates at a density of 2.5 · 105 cells/ml
or in 10 cm-diameter culture dishes (1 · 107 cells/
10ml/dish) and allowed to adhere at 37 °C in 5% CO2/
95% O2 for 2h. Immediately before the experiments,
culture medium was replaced by fresh medium without
FBS in order to avoid interference with radioim-
munoassay (Zingarelli et al., 1997) and cells were stim-
ulated as described.
Assessment of COX-1 activity
Cells were pretreated with test coumpounds for 15 min
and further incubated for 30 min with arachidonic acid
(AA) 15 · 10–6 M (Zingarelli et al., 1997). At the end of
the incubation the supernatants were collected for the
measurement of PGE2 by radioimmunoassay (Sautebin
et al.,1999). Test coumpounds were the following:
propolis, with and without CAPE (3 · 10–3–3 · 102
µgml–1), CAPE (2.8 · 10–4–28 µgml–1; 10–9–10–4 M),
galangin (2.7 · 10–4–27 µgml–1; 10–9–10–4 M),
pinocembrin (2.8 · 10–4–28 µgml–1; 10–9–10–4 M) caf-
feic acid (1.8 · 10–4–18 µgml–1; 10–9–10–4 M), ferulic
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post hoc test for multiple comparisons. A p value less
than 0.05 was considered to be statistically significant. 
j Results
Analysis of propolis deprived of CAPE
CAPE was undetectable in the residual propolis,
whereas caffeic acid and phenethyl alcool were abun-
dant in water solutions. The amounts of the other de-
tectable components of the original propolis were
roughly the same in the residual propolis (Fig.1).
No evident changes in the content of the original total
flavonoids and caffeic acid before and after the proce-
dure, have been observed. Total flavonoid content of
propolis with CAPE, expressed as galangin, was 9.04%;
CAPE content was 10.44%. Total acidity, expressed as
caffeic acid, was 13%. Total flavonoid content of propo-
lis without CAPE, expressed as galangin, was 8.5%.
Inhibition of COX-1 activity by test compounds
Stimulation of J774 macrophages with arachidonic
acid (15 · 10–6M) for 30 min induced a significant in-
crease (p < 0.001) of PGE2 (5.1 ± 0.3 ng · 106 cells)
levels in comparison to unstimulated control cells (0.32
± 0.06 ng · 106 cells).
acid (1.9 · 10–4–19 µgml–1; 10–9–10–4 M), cinnamic
acid (1.5 · 10–4–15 µgml–1; 10–9–10–4 M), chlorogenic
acids (3.5 · 10–4–35 µgml–1; 10–9–10–4 M). The tested
concentrations of CAPE and galangin corresponded to
those present in the extract.
Assessment of COX-2 activity
Cells were stimulated, for 24h, with lipopolysaccharide
(LPS, 10 µgml–1), to induce COX-2, in the absence or
presence of test compounds, at the concentrations pre-
viously reported. The supernatants were collected for
the measurement of PGE2 by radioimmunoassay
(Sautebin et al., 1999).
Statistical analysis 
In each experimental day, triplicate wells were used for
the various treatment conditions. Results are expressed
as the mean, for 4 experiments, of the % inhibition of
PGE2 production by test compounds in respect to control
samples. Data fit was obtained using the sigmoidal dose-
response equation (variable slope) (GraphPad software).
The IC50 and the 95% confidence intervals (reported in
bracket) were calculated by GraphPad Instat program
(GraphPad software). Inhibition curves were analyzed
and compared with two-way analysis of variance
(ANOVA). Data (ng of PGE2 produced) were analysed
by using one-way ANOVA followed by a Bonferroni
Fig. 1. Thin layer chromatogra-
phy (TLC) of original propolis
(line 1), water solutions (line 2),
residual propolis (line 3), CAPE
(line 4), phenethyl alcool (line
5) and caffeic acid (line 6).
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The ethanolic extract of propolis (3 · 10–1–3 · 102
µgml–1) significantly (p < 0.01 at the lowest concentra-
tion; p < 0.001 at all the other concentrations) and con-
centration-dependently inhibited PGE2 generation
(Fig.2), with an IC50 of 2.7 µgml–1 (1.3 to 5.8 µgml–1).
Same results were obtained with CAPE (28 · 10–3–28
µgml–1; 10–7–10–4 M) which significantly (p < 0.01 at the
lowest concentration; p < 0.001 at all the other concen-
trations) and concentration-dependently inhibited
prostanoid generation (fig. 2). The IC50 was 4.4 · 10–1
µgml–1 (3.3 to 6 · 10–1 µgml–1), corresponding to 1.5 ·
10–6M. The production of PGE2 was also significantly in-
hibited by galangin (27 · 10–3–27 µgml–1; 10–7–10–4 M),
but only from the concentration of 27 · 10–2 µgml–1 (p <
0.05; p < 0.01 at 27 · 10–1; p < 0.001 at 27 µgml–1) (fig.
2), with an IC50 of 3.7µgml–1 (1.4 to 10.2 µgml–1) corre-
sponding to 15 · 10–6M. The other compounds tested
(pinocembrin, caffeic, chlorogenic, ferulic and cinnamic
acids) did not inhibit, at all the concentrations tested
(10–7–10–4 M), prostanoid generation (data not shown).
To investigate the role of CAPE in the overall in-
hibitory activity of propolis we tested the action of the
ethanolic extract of propolis (3 · 10–1–3 · 102 µgml–1)
deprived of CAPE. The inhibition was significant only
Fig. 3. Inhibitory effect of an ethanolic extract of propolis
with (j) and without (h) CAPE (panel A), CAPE (.) and
galangin (r) (panel B) on PGE2 production by J774
macrophages stimulated with LPS (10 µgml–1) in presence or
absence of test compounds. The concentrations are expressed
as log µgml–1. Each point represents the mean for 4 experi-
ments performed in triplicate.
Fig. 2. Inhibitory effect of an ethanolic extract of propolis
with (j) and without (h) CAPE (panel A), CAPE (.) and
galangin (r) (panel B) on PGE2 production by J774
macrophages incubated with arachidonic acid (15 · 10–6 M)
for 30 min. Cells were pretreated for 15 min with test com-
pounds before the addition of arachidonic acid. The concen-
trations are expressed as log µgml–1. Each point represents
the mean for 4 experiments performed in triplicate.
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from the concentration of 3 µgml–1 (p < 0.05; p < 0.01
at 30, p < 0.001 at 300 µgml–1). This extract was about
ten times less potent than the extract containing CAPE
(Fig. 2), the IC50 being 30 µgml–1 (10 to 87 µgml–1).
Moreover the comparison of the inhibition curves
showed a significant difference (p < 0.001) between
propolis with and without CAPE.
Inhibition of COX-2 activity by test compounds
Stimulation with LPS (10 µgml–1) for 24h induced a
significant (p < 0.001) increase of PGE2 generation (28
± 3.4 ng · 106 cells) in comparison to unstimulated
control cells (1.32 ± 0.1 ng · 106 cells).
In the presence of increasing concentrations of the
ethanolic extract of propolis (3 · 10–3–30 µgml–1) a
concentration-dependent and significant (p < 0.01 at 3
· 10–2 µgml–1; p < 0.001 at all the other concentrations)
inhibition of PGE2 production was observed (Fig. 3)
with an IC50 of 4.8 · 10–2 µgml–1 (2.5 to 9.2  · 10–2
µgml–1). CAPE (2.8 · 10–4–2.8 µgml–1; 10–9–10–5 M),
exerted a similar significant (p < 0.01 at 2.8 · 10–4
µgml–1: p < 0.001 at all the other concentrations) and
concentration-dependent inhibition (Fig.3), with an
IC50 of 2 · 10–3 µgml–1 (6 · 10–4 to 6 · 10–3 µgml–1) (6.3
· 10–9 M). Galangin (2.7 · 10–4–2.7 µgml–1; 10–9–10–5
M) was also effective (Fig. 3), but the inhibition was
significant only from the concentration of 2.7 · 10–2
µgml–1 (p < 0.01; p < 0.001 at all the other concentra-
tions) . The IC50 was 3 · 10–2 µgml–1 (2 to 4 · 10–2
µgml–1) (120 · 10–9 M). The other compounds tested
pinocembrin, caffeic, chlorogenic, ferulic and cinnam-
ic acids did not inhibit, at all the concentrations tested
(10–9–10–5 (M) prostanoid generation (data not shown).
Next we tested the action of the ethanolic extract of
propolis without CAPE. This extract (3 · 10–3–30
µgml–1) significantly and concentration-dependently
inhibited PGE2 production but only from the concen-
tration of 3–10–1 µgml–1 (p < 0.05; p < 0.001 at the other
concentrations), resulting ten times less potent than the
extract contents CAPE (Fig. 3). The IC50 was 5.4 · 10–1
µgml–1 (1.8 · 10–1 to 1.6 µgml–1). Moreover the com-
parison of the inhibition curves showed a significant
difference (p < 0.001) between propolis containing
CAPE and propolis without CAPE. 
j Discussion
The antinflammatory activity of propolis is well known
although the exact mechanism of action is still under de-
bate. The inhibition of PG generation seems to be, at
least in part, the mechanism mainly responsible for this
property (Mirzoeva and Calder, 1996; Mezenes et al.,
1999). Moreover the complicated chemical composi-
tions of crude extract of propolis make very difficult to
establish which compounds are primarily involved.
Flavonoids and related compounds, which inhibit
arachidonic acid metabolism (Baumann et al., 1980), are
certainly involved, but other compounds may act syner-
gistically and contribute to the overall antinflammatory
activity (Ghisalberti, 1997). Recently it has been report-
ed that CAPE, the caffeic acid phenethyl ester, which is
present in the ethanolic extract of propolis, inhibits AA
metabolism in mouse peritoneal macrophages stimulat-
ed with LPS or A23187 ionophore (Mirzoeva and
Calder, 1996). In human oral epithelial cells and in a rat
model of inflammation CAPE exherts antinflammatory
activity by inhibiting the activity and expression of cy-
clooxygenase-2 (Michaluart et al., 1999). Moreover
CAPE seems to inhibit the activation by tumor necrosis
factor and other antinflammatoy agents, such as phorbol
ester, ceramide, hydrogen peroxide and okadaic acid, of
the transcription factor NF-k B (Natarajan et al, 1996)
which regulates the expression of many genes involved
in inflammation (Wulczyn et al., 1996). The inhibition
of NF-k B and TNF
a
has also been reported in a
macrophage cell line (NR 8383), in a classic epithelial
cell line (SW 620) and in a model of colitis in the rat
(Fitzpatrick et al., 2001). The antinflammatory activity
of CAPE through the modulation of NF-k B has also
been described in a rat model of carrageenin-induced
subcutaneous inflammation (Orban et al., 2000). 
In this study we have studied the effect of an ethano-
lic extract of propolis, with and without CAPE, and
some ot its components on COX-1 and COX-2 activity,
measured as PGE2 production, in J774macrophages.
Our results show that propolis concentration–depen-
dently inhibits COX-1 and COX-2 activity and link this
effect mainly to CAPE and galangin. In fact among the
compounds tested only CAPE and galangin were ac-
tive. Cinnamic, caffeic, chlorogenic and ferulic acids
were inactive on both COX-1 and COX-2 activity. It
has been previously reported (Huang et al., 1991) that
these compounds were unable to inhibit arachidonic
acid conversion to PGE2 and PGD2 by epidermal mi-
crosomes. The comparison of the inhibition curves and
the analysis of the IC50 indicate that, in our experimen-
tal model, CAPE is more potent than galangin. The
central role of CAPE is further supported by the evalu-
ation of the effect of the extract of propolis without
CAPE. In fact this extract was a less potent (about ten
times) inhibitor of COX isoforms when compared to
the extract containing CAPE. In our experimental con-
ditions the IC50 ratio COX-1/COX-2 for CAPE is about
200–300. Recently it has been reported that CAPE in-
hibits COX-1 (IC50 58 · 10–6 M) and COX-2 (IC50 82 ·
10–6 M) activity in a cell free assay, using baculovirus-
expressed human recombinant enzymes (Michaluart et
al., 1999), whithout any apparent selectivity. 
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In conclusion our results suggest that although both
CAPE and galangin contribute to the overall inhibitory
activity of propolis, CAPE gives a greater contribution.
Thus CAPE could be a usefull tool in the control of
pathologies characterized by an elevated PG biosyn-
thesis.
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